Scientist or Senior Scientist
Cell Biology, Immunology & In Vivo Pharmacology
Pay: $100,000 – $150,000 per year
Location: Rockville, MD (on-site)
About Us:
Founded in 2017 by scientists from Harvard Medical School and UCSF, Autonomous Therapeutics is developing first-in-class nucleic acid medicines across infectious disease and oncology indications.
Our platform fuses synthetic biology, synthetic chemistry, and therapeutic engineering to achieve a simple goal: target-activated (precision) medicines that are programmed to activate (only) in diseased cells. Imagine a chemotherapy that avoids your healthy cells.
You would join a team of 25 PhD scientists and engineers across synthetic biology, chemistry, immunology, cell biology, in vivo biology, and AI/robotics engineering in our 20,000 sq ft facility outside Washington, D.C.
The Role:
We are looking for an exceptional cell biologist, immunologist, or in vivo biologist to help develop first-in-class therapeutic candidates from discovery through IND.
This is a high-impact position for an outstanding experimental biologist with expertise in both in vitro and in vivo biology. You will have the opportunity to both discover new candidates and drive the preclinical translation of existing first-in-class candidates. The ideal candidate combines scientific passion and experimental rigor with the ability to translate cellular discoveries into preclinical data.
You will work closely with our synthetic chemistry, immunology, and in vivo biology teams to evaluate whether novel therapeutic candidates are potent, selective, mechanistically novel, and ready for advancement into safety, efficacy, and pre-IND studies.
You will report directly to the Head of Preclinical Biology and the President of R&D.
What You’ll Do:
Design, perform, and analyze in vitro and in vivo studies to evaluate novel therapeutic candidates.
Develop and optimize cell-based assays for potency, selectivity, mechanism of action, cellular delivery, and therapeutic response.
Use cell-based assay results to guide in vivo study design, biomarker selection, and interpretation of pharmacodynamic responses.
Evaluate preclinical efficacy, pharmacology, biodistribution, and safety data to enable candidate selection and advancement to IND-enabling studies.
Collaborate with synthetic biology, chemistry, immunology, and preclinical development teams.
Present data to leadership, pressure-test hypotheses, and help drive scientific decision-making across company programs.
Mentor junior scientists and help build a growing translational biology team.
About You
You have a PhD in Immunology, Virology, Cell Biology, Pharmacology, or a related field.
You also have 5+ years of experimental biology experience (including PhD work)—spanning both in vitro and in vivo research—with demonstrated expertise in ONE or more of the following:
Cell Biology & Immunology
Experience studying mammalian cell biology, immune-cell biology, innate immunity, cell signaling, host-pathogen interactions, or mechanisms of action (MOA) for novel therapeutic candidates.
Cell-Based Assays & Candidate Screening
Experience designing, optimizing, and interpreting cell-based assays to evaluate the safety and efficacy of novel therapeutic candidates, including assays for cellular uptake, viability, cytotoxicity, or immune activation using imaging, flow cytometry, qPCR, ELISA/MSD, high-throughput screening, or other quantitative biological readouts.
In Vivo Biology & Pharmacology
Experience designing, executing, analyzing, or interpreting in vivo studies to evaluate therapeutic candidates, including infectious disease models, inflammatory disease models, efficacy or pharmacodynamic readouts, tissue collection strategies, biodistribution, or PK/PD.
Additional Expertise in One or More of the Following is Preferred
Primary & Complex Cell Systems
Experience with difficult-to-culture primary immune cells, macrophages, PBMCs, epithelial cells, organoids, co-culture systems, or other translational models.
Therapeutic Models
Deep experience with infectious disease efficacy models, immunological or inflammatory disease models, PK/PD studies, biodistribution studies, or biomarker-driven in vivo pharmacology.
High-Throughput Biology
Experience with high-throughput screening, automation, assay miniaturization, image-based assays, or quantitative screening workflows.
Novel Therapeutic Modalities
Experience evaluating oligonucleotides (siRNA, ASO, aptamers), nucleic acid (mRNA) medicines, biologics, antibodies, immunotherapies, targeted delivery platforms, or other emerging therapeutic modalities.
Why Join Us:
Impact:
Help develop first-in-class medicines for infectious diseases and cancers.Scientific Breadth:
Gain expertise across synthetic chemistry, nucleic acid biology, cell biology, immunology, virology, and in vivo pharmacology.Compensation:
Highly competitive salary and equity (stock option) packages.Benefits:
Health, dental, and vision insurance
401(k) with employer matching
Paid time off
New Skills:
Work at the intersection of biology, therapeutic engineering, and AI/robotics, with opportunities to develop novel high-throughput screening systems in collaboration with our engineering team.
Culture:
Work alongside a highly collaborative team of scientists and engineers in a fast-moving biotech startup developing the next generation of precision medicines.
Hiring Info:
Work Authorization:
Candidates must be authorized to work in the United States.
Merit-Based:
Autonomous Therapeutics is an Equal Opportunity Employer. Hiring decisions are based on merit, qualifications, and business needs.